![](https://www.webhealthnetwork.com/img/webhealth-logo.png)
Immunoblastic Lymphadenopathy - 269 Studies Found
Completed |
: A Phase II Study of Rituximab Combined With CHOP in T-cell Angio-immunoblastic Lymphoma : Untreated T-cell Angioimmunoblastic Lymphoma : 2005-09-12 :
|
Completed |
: Fludarabine, Cyclophosphamide, and Thalidomide in Treating Patients With Angioimmunoblastic T-Cell Lymphoma : Lymphoma : 2009-08-12 :
|
Terminated |
: Cyclosporine in Treating Patients With Recurrent or Refractory Angioimmunoblastic T-Cell Lymphoma : Lymphoma : 2003-10-03 : Drug: cyclosporine Cyclosporine doses will be based on actual body weight unless actual body weight is & |
Recruiting |
: Anti-ICOS Monoclonal Antibody MEDI-570 in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma Follicular Variant or Angioimmunoblastic T-cell Lymphoma :
|
Completed |
: Study of Orally Administered AG-221 in Subjects With Advanced Solid Tumors, Including Glioma, and With Angioimmunoblastic T-cell Lymphoma, With an IDH2 Mutation Subjects With Advanced Solid Tumors, Including Glioma, and With Angioimmunoblastic T-cell Lymphoma, With an IDH2 Mutation :
|
Recruiting |
: A Study of Plitidepsin in Patients With Relapsed or Refractory Angioimmunoblastic T-cell Lymphoma : Lymphoma : 2017-01-16 : Drug: plitidepsin Other Name: APLD Aplidine |
Recruiting |
: Efficacy of a Treatment With CHOP and Lenalidomide in First Line in Angioimmunoblastic T-cell Lymphoma (AITL) : T-cell Lymphoma : 2012-01-20 : Drug: Lenalidomide Lenalidomide |
Recruiting |
: Risk Stratification of Nodal PTCL :
|
Recruiting |
: Immunotherapy in Peripheral T Cell Lymphoma - the Role of Alemtuzumab in Addition to Dose Dense CHOP :
|
Recruiting |
: CHOP vs GEM-P in 1st Line Treatment of T-cell Lymphoma, Multicentre Phase II Study :
|